StockData
ABVC BioPharma, Inc. logo

ABVC BioPharma, Inc. (ABVC) stock

ABVCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ECOC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 2/30
$0.94+0.03 (+3.30%)

Close on Nov 16, 2026Market cap $25.06MP/E –Yield –

ABVC BioPharma pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for ABVC BioPharma

ABVC BioPharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More ABVC BioPharma figures

See a number that looks wrong?